173 related articles for article (PubMed ID: 32773337)
41. Molecular-derived estimation of risk of malignancy for indeterminate thyroid cytology diagnoses.
Ohori NP; Landau MS; Manroa P; Schoedel KE; Seethala RR
J Am Soc Cytopathol; 2020; 9(4):213-220. PubMed ID: 32336670
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
Elliott Range D; Jiang XS
Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682
[TBL] [Abstract][Full Text] [Related]
43. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
44. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
45. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population.
Vuong HG; Suzuki A; Na HY; Tuyen PV; Khuy DM; Nguyen HC; Jitpasutham T; Abelardo A; Amano T; Park SY; Jung CK; Hirokawa M; Katoh R; Kakudo K; Bychkov A
Am J Clin Pathol; 2021 Apr; 155(5):680-689. PubMed ID: 33269383
[TBL] [Abstract][Full Text] [Related]
46. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases.
Seningen JL; Nassar A; Henry MR
Diagn Cytopathol; 2012 May; 40 Suppl 1():E27-32. PubMed ID: 22619156
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy.
Raparia K; Min SK; Mody DR; Anton R; Amrikachi M
Arch Pathol Lab Med; 2009 May; 133(5):787-90. PubMed ID: 19415954
[TBL] [Abstract][Full Text] [Related]
48. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
[TBL] [Abstract][Full Text] [Related]
49. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
50. Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?
Srbova L; Gabalec F; Ryska A; Cap J
Cytopathology; 2015 Aug; 26(4):231-7. PubMed ID: 25077794
[TBL] [Abstract][Full Text] [Related]
51. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
Hang JF; Lilo MT; Bishop JA; Ali SZ
Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
[TBL] [Abstract][Full Text] [Related]
53. Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category.
Mahajan A; Lin X; Nayar R
Cytopathology; 2013 Apr; 24(2):85-91. PubMed ID: 22356185
[TBL] [Abstract][Full Text] [Related]
54. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
55. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
Vuong HG; Tran TTK; Bychkov A; Jung CK; Nakazawa T; Kakudo K; Katoh R; Kondo T
Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
[No Abstract] [Full Text] [Related]
56. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
Li W; Sciallis A; Lew M; Pang J; Jing X
Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
[TBL] [Abstract][Full Text] [Related]
57. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
Özkara SK; Bayrak BY; Turan G
Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
[TBL] [Abstract][Full Text] [Related]
58. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
Goldstein RE; Netterville JL; Burkey B; Johnson JE
Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
[TBL] [Abstract][Full Text] [Related]
59. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
60. Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma.
Zhang X; Howell JM; Huang Y
Endocr Pathol; 2018 Dec; 29(4):346-350. PubMed ID: 30203321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]